Portage Biotech Analyst Ratings
BenzingaJan 9 02:36
Analysts Offer Insights on Healthcare Companies: Harpoon Therapeutics (HARP), Portage Biotech Inc (PRTG) and Ambrx Biopharma (AMAM)
TipRanksJan 9 02:00
HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $6
BenzingaNov 30, 2023 04:01
Portage Biotech Analyst Ratings
BenzingaNov 30, 2023 04:00
Portage Biotech Inc: A Buy Rating Amid Future Catalysts and Strategic Acquisitions
TipRanksNov 30, 2023 00:35
Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target
BenzingaSep 7, 2023 23:38
Portage Biotech Analyst Ratings
BenzingaSep 7, 2023 23:37
Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target
BenzingaAug 31, 2023 21:23
Portage Biotech Analyst Ratings
BenzingaAug 31, 2023 21:22
Portage Biotech Inc (PRTG) Receives a Buy From H.C. Wainwright
TipRanksAug 2, 2023 18:25
HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9
BenzingaAug 2, 2023 18:23
Portage Biotech Analyst Ratings
BenzingaAug 2, 2023 18:23
Cantor Fitzgerald Maintains Overweight on Portage Biotech, Lowers Price Target to $11
BenzingaAug 1, 2023 21:26
Portage Biotech Analyst Ratings
BenzingaAug 1, 2023 21:25
HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating
MT NewswiresDec 1, 2022 23:22
Portage Biotech Analyst Ratings
Benzinga Analyst RatingsDec 1, 2022 19:16
HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $21
Benzinga Real-time NewsDec 1, 2022 19:15
Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating
MT NewswiresNov 30, 2022 21:56
Portage Biotech Analyst Ratings
Benzinga Analyst RatingsNov 30, 2022 20:21
Oppenheimer: maintain the Portage Biotech (PRTG.US) better than the market rating, with the target price adjusted to $18.00 from $26.00.
Zhitong FinanceNov 30, 2022 20:00
No Data
No Data